Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 26 , ISSUE 5 ( May, 2022 ) > List of Articles


Non-hypertension-associated Posterior Reversible Encephalopathy Syndrome in COVID-19

Dhruva Sharma, Deeksha S Tomar, Sachin Gupta

Keywords : COVID-19 infection, Inflammation, Posterior reversible encephalopathy syndrome

Citation Information : Sharma D, Tomar DS, Gupta S. Non-hypertension-associated Posterior Reversible Encephalopathy Syndrome in COVID-19. Indian J Crit Care Med 2022; 26 (5):641-642.

DOI: 10.5005/jp-journals-10071-24218

License: CC BY-NC 4.0

Published Online: 20-05-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Background: Coronavirus disease-2019 (COVID-19) infection-related neurological events are not uncommon but presenting as posterior reversible encephalopathy syndrome (PRES) without hypertension is a very rare presentation and requires a high index of suspicion. Case summary: We report a case of a middle-aged female who presented with severe COVID-19 disease with no neurological symptoms. She complained of diminished vision on day 7 of the illness and underwent an MRI brain to rule out an ischemic stroke but the findings were suggestive of PRES. She had no episode of hypertension during the hospital stay. Probably severe COVID-related inflammation was the reason for such a presentation. Conservative management resolved the issue and her symptoms weaned off. Conclusion: Severe COVID disease can lead to PRES-like symptoms and requires neuroimaging to validate it. Conservative management is the best treatment for such patients.

  1. Zirpe KG, Dixit S, Kulkarni AP, Sapra H, Kakkar G, Gupta R, et al. Pathophysiological Mechanisms and Neurological Manifestations in COVID-19. Indian J Crit Care Med 2020;24(10):975–980. DOI: 10.5005/jp-journals-10071-23592.
  2. Goel K, Kumar A, Diwan S, Kohli S, Sachdeva HC, Usha G, et al. Neurological manifestations of COVID-19: a series of seven cases. Indian J Crit Care Med 2021;25(2):219–223. DOI: 10.5005/jp-journals-10071-23723.
  3. McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, SantaCruz KS, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189:904–912. DOI: 10.2214/AJR.07.2024.
  4. Roth C, Ferbert A. The posterior reversible encephalopathy syndrome: what's certain, what's new? Pract Neurol 2011;11:136–144. DOI: 10.1136/practneurol-2011-000010.
  5. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010;85:427–432. DOI: 10.4065/mcp.2009.0590.
  6. Bartynski W. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008;29:1043–1049. DOI: 10.3174/ajnr.A0929.
  7. Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care 2020;24:353. DOI: 10.1186/s13054-020-03062-7.
  8. Labandeira-Garcia JL, Rodríguez-Perez AI, Garrido-Gil P, Rodriguez-Pallares J, Lanciego JL, Guerra MJ. Brain renin-angiotensin system and microglial polarization: implications for aging and neurodegeneration. Front Aging Neurosci 2017;9:129. DOI: 10.3389/fnagi.2017.00129.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.